We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
-3.95%
1 Year Est. Return
+41.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.61B
AUM Growth
-$328M
Cap. Flow
-$92.4M
Cap. Flow %
-2.56%
Top 10 Hldgs %
37.37%
Holding
513
New
16
Increased
123
Reduced
150
Closed
29

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$35.4M
2
MSFT icon
Microsoft
MSFT
+$13.5M
3
NVDA icon
NVIDIA
NVDA
+$13.3M
4
AVGO icon
Broadcom
AVGO
+$7.09M
5
AMZN icon
Amazon
AMZN
+$5.26M

Sector Composition

Rank Sector Weight
1 Technology 32.67%
2 Financials 13.22%
3 Consumer Discretionary 11.84%
4 Communication Services 11.62%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
26
Lam Research
LRCX
$316B
$26.1M 0.72%
122,023
+7,710
+7% +$1.72M
BAC icon
27
Bank of America
BAC
$429B
$25.6M 0.71%
524,687
+9,898
+2% +$511K
PEP icon
28
PepsiCo
PEP
$196B
$25.3M 0.7%
162,671
+4,587
+3% +$715K
AMGN icon
29
Amgen
AMGN
$209B
$22.1M 0.61%
62,881
-1,476
-2% -$526K
RY icon
30
Royal Bank of Canada
RY
$287B
$21M 0.58%
93,431
ABT icon
31
Abbott
ABT
$187B
$20M 0.55%
194,851
-600
-0.3% -$67.7K
GS icon
32
Goldman Sachs
GS
$289B
$19.1M 0.53%
22,550
+784
+4% +$699K
KLAC icon
33
KLA
KLAC
$222B
$18.7M 0.52%
126,690
+4,750
+4% +$695K
ISRG icon
34
Intuitive Surgical
ISRG
$127B
$18.2M 0.5%
39,440
-1,801
-4% -$911K
TJX icon
35
TJX Companies
TJX
$179B
$18.2M 0.5%
113,724
-905
-0.8% -$141K
GILD icon
36
Gilead Sciences
GILD
$165B
$17.7M 0.49%
126,803
-4,126
-3% -$578K
UNH icon
37
UnitedHealth
UNH
$382B
$17.6M 0.49%
65,152
-350
-0.5% -$104K
T icon
38
AT&T
T
$164B
$16.8M 0.47%
581,227
-2,870
-0.5% -$76.7K
PFE icon
39
Pfizer
PFE
$143B
$16.4M 0.45%
582,677
-3,251
-0.6% -$86.6K
AEM icon
40
Agnico Eagle Mines
AEM
$72.2B
$16M 0.44%
56,529
+6,945
+14% +$1.45M
VZ icon
41
Verizon
VZ
$197B
$15.5M 0.43%
308,740
-23,222
-7% -$1.08M
C icon
42
Citigroup
C
$213B
$14.8M 0.41%
130,467
-1,567
-1% -$178K
MS icon
43
Morgan Stanley
MS
$319B
$14.5M 0.4%
88,348
-544
-0.6% -$94.2K
IBM icon
44
IBM
IBM
$213B
$14.5M 0.4%
59,779
-3,543
-6% -$959K
NEM icon
45
Newmont
NEM
$96.2B
$14.3M 0.4%
132,470
+10,748
+9% +$1.24M
WELL icon
46
Welltower
WELL
$174B
$14.3M 0.4%
72,270
-3,345
-4% -$661K
DE icon
47
Deere & Co
DE
$165B
$14.2M 0.39%
25,121
+34
+0.1% +$19.2K
ITW icon
48
Illinois Tool Works
ITW
$84.1B
$13.9M 0.38%
53,395
-395
-0.7% -$107K
TMO icon
49
Thermo Fisher Scientific
TMO
$214B
$13.8M 0.38%
28,169
-2,116
-7% -$1.15M
ORCL icon
50
Oracle
ORCL
$339B
$13.8M 0.38%
93,988
-4,666
-5% -$758K

Similar funds

Avanza Fonder's Q1 2026 Portfolio in Review

As of Q1 2026, Avanza Fonder held 513 positions worth $3.61B, down 8.3% from $3.94B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Avanza Fonder's Q1 2026 filing shows 16 new, 123 increased, 150 reduced and 29 closed positions. Its largest new stake was Nutrien: 7,208 shares worth $757K. The largest sale was Berkshire Hathaway Class B, an estimated $35.4M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Avanza Fonder's largest Q1 2026 buy was Nutrien: 7,208 shares worth $757K.
  • Avanza Fonder added most to Procter & Gamble in Q1 2026, an estimated $2.09M increase.
  • Avanza Fonder's biggest Q1 2026 reduction was Microsoft, cutting an estimated $13.5M.
  • Avanza Fonder fully exited Berkshire Hathaway Class B in Q1 2026, selling an estimated $35.4M.
  • Avanza Fonder's ten largest holdings make up 37% of its $3.61B portfolio in Q1 2026.
  • Avanza Fonder opened 16 new positions and closed 29 in Q1 2026.
  • Avanza Fonder's portfolio value fell 8.3% quarter-over-quarter to $3.61B.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.